Jubilant Pharmova Limited (JUBLPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Jubilant Pharmova Limited (NSE: JUBLPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 14 Nov 2026, the share price was ₹964.00, P/E 39.6, ROE 6.53%.
Get the AI verdict on JUBLPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
JUBLPHARMA chart with trendlines
Is JUBLPHARMA a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Jubilant Pharmova Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
JUBLPHARMA key facts
| Price and valuation | |
|---|---|
| Share price | ₹964.00 |
| Market cap | ₹15,358 Cr |
| P/E ratio | 39.6 |
| P/B ratio | 2.17 |
| EPS | ₹22.11 |
| Book value per share | ₹445.00 |
| Dividend yield | 0.52% |
| 52-week range | |
| 52-week high | ₹1,162.00 |
| 52-week low | ₹786.05 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 47.67% |
| FIIs | 15.37% |
| DIIs | 13.01% |
| Public | 23.38% |
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.